The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome
Official Title: Minimal Stimulation or Clomiphene Citrate as First Line Therapy in Women With Polycystic Ovary Syndrome
Study ID: NCT01157312
Brief Summary: The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(PCOS).
Detailed Description: All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation. In group A (minimal stimulation), 2 vials of highly purified uFSH , 150 IU (Fostimon; IBSA, Lugano, Switzerland, 75 IU/vial) were given IM on cycle day 9. A total of 3 cycles was offered to each group.
Minimum Age: 20 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Mansoura University Hospitals,OB/GYN department, Mansoura, Dakahlia Governorate, Egypt
Name: Hatem Abu Hashim, MD MRCOG
Affiliation: Mansoura University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Mohamed F Bazeed, MD
Affiliation: Mansoura University Hospital
Role: STUDY_DIRECTOR
Name: Ibrahim Abd Elaal, MD
Affiliation: Mansoura University Hospital
Role: STUDY_CHAIR